中文
EN
News Center
News Center
Viwit Pharmaceuticals to Showcase at DCAT Week 2026, Invites Global Partners to New York
Author：
VIWIT
Release Time：
2026-03-10
As spring unfolds, the global life sciences community will once again turn its attention to New York City for the highly anticipated 2026 DCAT Week. As a dedicated player in the pharmaceutical and healthcare sector, Viwit Pharmaceuticals will bring its deep insights into industry frontiers and proactive exploration of future trends to this premier event in New York.
From March 23 to 26, 2026, Mr. Augie Aswan, General Manager of Global Business Development at Viwit Pharmaceuticals, will lead the team to attend this significant gathering, engaging in in-depth discussions with global partners to foster and deepen business collaborations. As an enterprise deeply rooted in the pharmaceutical and health field, Viwit Pharmaceuticals is committed to innovation-driven growth. The company has strategically developed an integrated "API + Formulation" industrial chain and, leveraging its global manufacturing and service network, consistently serves the international market. Currently, all three of Viwit's manufacturing sites have successfully passed US FDA inspection, equipped with robust capabilities for dual filing in China and the US. Building on this foundation, Viwit aims to explore innovative opportunities and co-create a new chapter of synergistic development with partners worldwide.
About DCAT Week
DCAT Week 2026 will take place from March 23 to 26 in New York City. The event is organized by the Drug, Chemical & Associated Technologies Association (DCAT), a non-profit, member-supported, volunteer-led organization dedicated to fostering collaboration and growth among its global membership. Each year, over 700 member companies from around the world, encompassing the global biopharmaceutical industry and its upstream and downstream supply chains, participate in this industry event. Unlike a traditional trade show, DCAT Week is a unique, dynamic, and diversified week-long program of events designed to facilitate deep networking, promote strategic partnerships, and help companies stay at the forefront of the evolving industry.
About Viwit Pharmaceuticals
Founded in 2006, Viwit Pharmaceuticals is a pharmaceutical and healthcare enterprise integrating R&D, production, and marketing, driven by technological innovation. The company is dedicated to building a platform for biomedical innovation and creation to serve public clinical needs. Viwit has been recognized as a National High-Tech Enterprise and a National "Little Giant" Specialized and Sophisticated Enterprise, among other honors. It has established 12 provincial-level or higher R&D platforms, including a National Enterprise Technology Center and a Key Laboratory in Shandong Province, with multiple technologies reaching internationally leading levels. Viwit Pharmaceuticals consistently adheres to innovation as its cornerstone, continuously providing high-quality products and solutions to global customers and helping accelerate the availability of innovative medicines for patients worldwide.